For more than two decades, Control Bionics has built its identity around EMG science and the practical challenge of giving people access to communication and measurable physical recovery. The company develops non-invasive neural-signal technology for people with complex physical needs, as well as for clinicians and researchers working to understand neuromuscular activity. Its platform is cleared by the FDA, TGA, and CE and is deployed internationally.
FDA registration
Registration
TGA registration
Registration
CE registration
Registration
NDIS-registered provider
Registration
TGA
Quality certification
CE
Quality certification
Precision NeuroscienceCo-founded by neurosurgeon and electrical engineer Benjamin Rapoport, Precision Neuroscience brings clinical experience directly into the development of brain–computer interfaces. The company makes its Layer 7 cortical interface in-house at a 22,000-square-foot MEMS fabrication facility in Addison, Texas, with an initial focus on helping people with paralysis operate digital devices through thought.
Naqi Logix IncFounded by inventor Dave Segal after a friend’s spinal-cord injury, Naqi Logix develops earbud-based neural interfaces that translate biosignals, facial micro-gestures and head movements into hands-free, voice-free control of digital devices. The Vancouver company’s platform is designed to make computers, wheelchairs, robotics and other connected systems more accessible without cameras, screens or implants. Naqi’s work has earned recognition including TIME’s Best Inventions of 2023 and a 2024 Gold Edison Award for Social & Cultural Impact.
NeuvotionLed by founder and CEO Chad Bouton, Neuvotion develops AI-guided brain-body interface technologies for neurorecovery, including non-invasive stimulation platforms and minimally invasive brain-computer interfaces. The company combines medical-device development experience with clinical expertise in spinal cord injury, stroke, rehabilitation, and neurosurgery to pursue technologies that can help restore movement and independence.
SensarsSensars develops implantable neuroprosthetic and neurostimulation systems designed to restore protective sensation in people with diabetic neuropathy and limb loss. Its SENSY platform combines nerve-implanted electrodes with smart wearable insoles, and preliminary human trials have demonstrated sensory restoration, improved gait and reduced pain. The Swiss-founded company’s work has appeared in more than 25 peer-reviewed publications and received FDA Breakthrough Device Designation.